Cardiovascular-renal-metabolic risk: early identification by the general practitioner
Article Sidebar
Main Article Content
Abstract
The large link of pathophysiological interactions between obesity, type 2 diabetes mellitus (DM), cardiovascular disease (CVD), and chronic kidney disease (CKD) has been defined as cardiovascular-renal-metabolic syndrome (CKM) by the American Heart Association (AHA).
This review examines pathophysiological mechanisms, risk factors and their management in general practice.
In this context it’s easier to promote prevention and therapy in a way that is personalized and adjustable to the social context which patients belong: that is significant because the great potential of improvement in patient with CKM.
This review reports useful approaches regarding assistance to screening, patient education, and initial therapy of CKM. It is also highlighted when it’s imperative the interdisciplinary coordination of care with the specialist physician to prevent adverse clinical outcomes, in particular
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Sneha A S et al. - Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review- 2024 Feb;49(2):102344. doi: 10.1016/j.cpcardiol.2023.102344. Epub 2023 Dec 14 .
Ronco C et al. - Cardiorenal syndrome- J AM Coll Cardiol 2008;52:1527-39.
Sowers J R et al. - The Role of Overweight and Obesity in the Cardiorenal Syndrome -Cardiorenal Med 2011; 1:5-12.
Yano Y et al. - Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study - Hypertension 2016;68.
Wong R J et al. - Trends in liver disease etiology among adults awaiting liver transplantation in the United States - JAMA new open 2020;3.
Neeland IJ et al. - Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement - Lancet Diabetes Endocrinol. 2019;7.
Sheng X et al. - Systematic integrated analysis of genetic and epigenetic variation in diabetic kidney disease - Proc Natl Acad Sci U S A. 2020;117:29013– 29024. doi: 10.1073/pnas.2005905117.
Afkarian M et al. - Kidney disease and increased mortality risk in type 2 diabetes - J Am Soc Nephrol. 2013;24:302–308. doi: 10.1681/ASN.20120 70718.
Apovian C M -Obesity: definition, comorbidities, causes, and burden - Am J Manag Care. 2016 Jun;22(7 Suppl):s176-85.
Greenstein A S - Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients - Circulation.(2009)119 12): 1661–70.
Ward Z J - Association of body mass index with health care expenditures in the United States by age and sex - PLoS Uno. (2021) 16 (3):1– 14. 10.1371.
Mancia G et al. – 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension, Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA) - J ipertension. (2023) 41 (12):1874–2071.
Kannel W B et al.- The relation of adiposity to blood pressure and development of hypertension. The Framingham study - Ann Intern Med. (1967) 67 (1): 48–59.
Volpe M et al. - Obesity and cardiovascular disease: An executive document on pathophysiological and clinical links promoted by the Italian Society of Cardiovascular Prevention - Front Cardiovasc Med. (2023) 10.
Rugarli. Medicina Interna Sistematica, VIII Edizione. Cap 3: Ipertensione Arteriosa: EDRA S.p.A, 2021.
Eckel R H et al. - The metabolic syndrome – Lancet.2005 Apr;365(9468):1415-28.
Metzger M et al. - A Narrative Review of Management Strategies for Common Symptoms in Advanced CKD - Kidney Int. Rep. 2021 Apr; 6(4): 894–904.
Larque E et al. - From conception to infancy: early risk factors for childhood obesity- Nat Rev Endocrinol 2019; 15:456-478.
Brown CL et al. - Addressing childhood obesity: opportunities for prevention - Pediatr Clin North Am 2015;62:1241-1261.
Longo M et al. - Adipose tissue dysfunction as determinant of obesity-associated metabolic complications - Int J Mol Sci 2019; 20:2358.
Ndumele E et al. - Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association - Circulation 2023;148:20.
Documento ufficiale della Società Italiana dell’Ipertensione Arteriosa: sulla gestione dell’ipertrigliceridemia nel paziente iperteso, 2024.
Rugarli et al. - Cap 81: Obesità e Sindrome Metabolica - Medicina Interna Sistematica, VIII Edizione. EDRA S.p.A, 2021.
Webster AC et al. - Chronic kidney disease - Lancet. 2017 25;389(10075):1238-1252.
Perone F et al. - Obesity and Cardiovascular Risk: Systematic Intervention Is the Key for Prevention - Healthcare 2023;11:902.
Visco V et al. - Interventions to Address Cardiovascular Risk in Obese Patients: Many Hands Make Light Work- J Cardiovasc Dev Dis 2023; 10(8):327.
Torreggiani M et al. - Spontaneously Low Protein Intake in Elderly CKD Patients: Myth or Reality? Analysis of Baseline Protein Intake in a Large Cohort of Patients with Advanced CKD - Nutrients 2021;13(12):4371.
2024 ESC Guidelines for the management of elevated blood pressure and hypertension -European Health Journal, 2024; ehae178.
Parcha V et al. - Coronary Artery Calcium Score for Personalization of Antihypertensive Therapy: A Pooled Cohort Analysis - Hypertension AHA,77(4) 120.16689.